Jpmorgan Chase & Co »

Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Neurocrine Biosciences Inc Note 2.250 5/1

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences Inc Note 2.250 5/1 held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences Inc Note 2.250 5/1 by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.9k 4.0k 1.73
2023-09-30 $89k 59k 1.50
2023-06-30 $75k 59k 1.27
2023-03-31 $13k 10k 1.30
2022-06-30 $1.4M 1.1M 1.33
2022-03-31 $199k 152k 1.31
2021-12-31 $381k 304k 1.25
2021-03-31 $5.5M 4.1M 1.36
2020-12-31 $4.9M 3.5M 1.39
2020-09-30 $2.4M 1.7M 1.40
2020-06-30 $2.9M 1.8M 1.66
2020-03-31 $2.5M 2.0M 1.28
2019-12-31 $5.6M 3.7M 1.53
2019-09-30 $6.1M 4.5M 1.37
2019-06-30 $4.4M 3.4M 1.30
2019-03-31 $3.6M 2.7M 1.33
2018-12-31 $1.2M 996k 1.19
2018-09-30 $4.1M 2.4M 1.72
2018-06-30 $3.2M 2.2M 1.46